Cohort Network for Adolescents and Youth With multipLe Mental Health Conditions
NCT07699159, Recruiting, Centre for Addiction and Mental Health
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Cohort Network for Adolescents and Youth With multipLe Mental Health Conditions | ClinicalTrials.gov |
| NCT number | NCT07699159 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Enrollment | 1,620 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Centre for Addiction and Mental Health | ClinicalTrials.gov |
| Conditions | Multiple Mental Health Conditions, Child Mental Health, Youth Mental Health | ClinicalTrials.gov |
| First posted | 2026-07-13 | ClinicalTrials.gov |
| Last updated | 2026-07-13 | ClinicalTrials.gov |
Registered outcomes 96
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Diagnostic Assessment for the Health Spectrum | Baseline and 24 months | The Diagnostic Assessment for the Health Spectrum (DASH) is a semi-structured screener and interview that evaluates a broad range of psychiatric symptoms and associated symptoms. It also assesses a number of physical health symptoms. The DASH is based on the core structure of the Schedule for Affective Disorders and Schizophrenia-SADS and Kiddie-SADS, and includes features of a number of other structured interviews of psychopathology. It provides a diagnostic spectrum in addition to categorical diagnoses that are aligned to the DSM-IV and DSM-5. The completed interview yields a narrative report and summary for clinicians and researchers. There are three versions (adult, child, and parent on child) which take approximately 90-240+ minutes to complete. | ClinicalTrials.gov |
| Primary | Adolescent Health History | Baseline, 12 months, 24 months | Youth and caregivers will be asked to self-report the presence of health conditions using the Adolescent Health History measure to indicate whether the youth has in the past or currently has any of over 40 common mental or physical health conditions listed. Youth will also be able to add up to four other conditions not listed. | ClinicalTrials.gov |
| Primary | Assessment of Quality of Life | Baseline, 3 months, 6 months, 12 months, 18 months, 24 months | The Assessment of Quality of Life (AQoL) measures 5 dimensions: illness, independent living, social relationships, physical senses and psychological well being. Each dimension is measured by three items (a total of 15 items). Total scores can range from a minimum of 20 to a maximum of 99, with higher scores indicating poorer quality of life. | ClinicalTrials.gov |
| Primary | Brain-CODE Demographic Form | Baseline, 12 months, 24 months | The Brain-CODE Demographic Form is a standard form developed by Brain-CODE to capture demographic information from participants. | ClinicalTrials.gov |
| Primary | Brain-CODE Medical History Form incorporating Developmental History Questionnaire (DHQ) Items | Baseline, 12 months, 24 months | The Brain-CODE Medical History Form is a standard form developed by Brain-CODE to capture medical history in participants. | ClinicalTrials.gov |
| Primary | Canadian Health Survey on Children and Youth (CHSCY) Childhood Experiences Scale | Baseline, 12 months, 24 months | The Canadian Health Survey on Children and Youth (CHSCY) Childhood Experiences Scale includes 10 items assessing youth's self-reported exposure to different forms of maltreatment by their caregivers, including physical, sexual and emotional abuse, neglect, as well as exposure to violence between caregivers. One additional item captures youth's exposure to corporal punishment. Items have been administered in population-based studies that include samples of youth and adults, as well as clinical observational studies and trials. Total scores can range from a minimum of 10 to a maximum of 50, with higher scores indicating more negative experiences. | ClinicalTrials.gov |
| Primary | Child and Youth Resilience Measure | Baseline, 12 months, 24 months, 36 months | The Child and Youth Resilience Measure is a screening tool to explore the resources (individual, relational, communal and cultural) available to individuals that may bolster their resilience. Individuals aged 24+ will be asked to complete the Adult Resilience Measure. This measure includes multiple subscale scores assessing different domains, with scores interpreted separately by subscale. | ClinicalTrials.gov |
| Primary | The Columbia Suicide Severity Rating Scale | Baseline, 24 months | The Columbia Suicide Severity Rating Scale is a validated and widely used rater-administered measure of suicidal ideation and behaviour, and non-suicidal self-injury. It will be administered to all participants. This measure includes multiple subscale scores assessing different domains, with scores interpreted separately by subscale. | ClinicalTrials.gov |
| Primary | Self-Injurious Thoughts and Behaviours Interview | Baseline, 24 months | The Self-Injurious Thoughts and Behaviours Interview (SITBI) measures self-injurious thoughts and behaviors. | ClinicalTrials.gov |
| Primary | Canadian Health Survey on Children and Youth (CHSCY) Bullying Scale | Baseline, 12 months, 24 months | The Canadian Health Survey on Children and Youth (CHSCY) Bullying Scale includes 10 items and is designed to assess youth exposure to bullying in the preceding 12 months. Items capture both the type and frequency of bullying, with types of bullying covered by the measure including verbal, physical, relational, and online forms of bullying. Response options are captured on an ordinal scale encompassing: Never, A few Times a Year, Monthly, Weekly, Daily. Total scores can range from a minimum of 10 to a maximum of 50, with higher scores indicating more experiences with bullying. | ClinicalTrials.gov |
| Primary | Difficulties in Emotion Regulation Scale Short Form | Baseline, 12 months, 24 months, 36 months | The Difficulties in Emotion Regulation Scale Short Form is an 18-item measure used to identify emotional regulation issues. The measure covers 4 dimensions of emotional regulation: awareness and understanding of emotions; acceptance of emotions; the ability to engage in goal-directed behavior and refrain from impulsive behavior when experiencing negative emotions; and access to emotion regulation strategies perceived as effective. Total scores can range from a minimum of 18 to a maximum of 90, with higher scores indicating more difficulties with emotion regulation. | ClinicalTrials.gov |
| Primary | Eating Disorder Examination Questionnaire (EDE-QS) Short Form | Baseline, 3 months, 6 months, 12 months, 18 months, 24 months | The Eating Disorder Examination Questionnaire (EDE-QS) Short Form is a 12-item, self-report questionnaire capturing eating disorder symptoms. Response options are anchored on a 4-point ordinal response scale that captures symptoms over the preceding 7 days. Total scores can range from a minimum of 0 to a maximum of 36, with higher scores indicating the presence of more eating disorder symptoms. | ClinicalTrials.gov |
| Primary | General Anxiety Disorder-7 | Baseline, 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 42 months | The General Anxiety Disorder-7 (GAD-7) measures presence and severity of Generalized Anxiety Disorder. Total scores can range from a minimum of 0 to a maximum of 21, with higher scores indicating greater presence and severity of anxiety symptoms. | ClinicalTrials.gov |
| Primary | General Behaviour Inventory-10 Mania | Baseline, 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 42 months | The General Behaviour Inventory-10 Mania measures the presence and severity of mania. Total scores can range from a minimum of 0 to a maximum of 30, with higher scores indicating greater presence and severity of mania. | ClinicalTrials.gov |
| Primary | General Life Satisfaction | Baseline, 18 months, 30 months | A singular question from the Canadian Social Survey - Quality of Life and Energy Consumption Behaviours measure will be administered to determine life satisfaction. Total scores can range from a minimum of 0 to a maximum of 10, with higher scores indicating greater life satisfaction. | ClinicalTrials.gov |
| Primary | The Goal-Based Outcome (GBO) Tool | Baseline, 3 months, 6 months, 12 months, 18 months, 24 months | The Goal-Based Outcome (GBO) Tool aims to measure the progress and outcomes of an intervention in a simple way. It can be applied in any setting and is currently available in 9 languages. The child GBO tool contains a record sheet whereby up to 3 goals with their descriptions can be written down, followed by a goal rating sheet with descriptions and a scale ranging from 0 (Goals not at all met) to 10 (Goal reached). A goal progress chart at the end can be used to rate the progress of the goal across 12 sessions. | ClinicalTrials.gov |
| Primary | Internalized Stigma of Mental Illness | Baseline | The Internalized Stigma of Mental Illness (ISMI) scale is a questionnaire measuring self-stigma among persons with psychiatric disorders. This measure includes multiple subscale scores assessing different domains, with scores interpreted separately by subscale. | ClinicalTrials.gov |
| Primary | International Sedentary Assessment Tool | Baseline, 3 months, 6 months, 12 months, 18 months, 24 months | This measure consists of two parts. The first part has six items, and asks questions based on typical weekday activity in the last week. The second part also includes six items and asks questions pertaining to typical weekend activities within the last week. Higher scores equate to more sedentary behaviors in a participant. | ClinicalTrials.gov |
| Primary | McMaster Family Functioning Scale | Baseline, 12 months, 24 months, 36 months | The McMaster Family Functioning Scale is a shorter 12-item assessment developed from The McMaster Family Assessment Device, which is a 60-item questionnaire that measures an individual's perceptions of their family. Total scores can range from a minimum of 12 to a maximum of 48, with higher scores indicating more positive perceptions of family. | ClinicalTrials.gov |
| Primary | Treatment Log | Baseline, 6 months, 18 months, 24 months, 30 months, 36 months, 42 months | This inventory records prescribed treatment and medication, adherence and tolerability every 6 months. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 75
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 678037 | BACKGROUND | PubMed |
| 2748771 | BACKGROUND | PubMed |
| 9204677 | BACKGROUND | PubMed |
| 9255702 | BACKGROUND | PubMed |
| 9691720 | BACKGROUND | PubMed |
| 9808931 | BACKGROUND | PubMed |
| 10472152 | BACKGROUND | PubMed |
| 10587984 | BACKGROUND | PubMed |
| 10909877 | BACKGROUND | PubMed |
| 10937431 | BACKGROUND | PubMed |
| 10945922 | BACKGROUND | PubMed |
| 12964174 | BACKGROUND | PubMed |
| 15183601 | BACKGROUND | PubMed |
| 15466849 | BACKGROUND | PubMed |
| 15486169 | BACKGROUND | PubMed |
| 15719529 | BACKGROUND | PubMed |
| 16962074 | BACKGROUND | PubMed |
| 17178616 | BACKGROUND | PubMed |
| 17329713 | BACKGROUND | PubMed |
| 17440198 | BACKGROUND | PubMed |
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 11
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Delay Discounting | Primary outcome | ConductCognition |
| Dimensional Change Card Sort | Primary outcome | ConductCognition |
| Emotional Stroop Task | Primary outcome | ConductCognition |
| Eriksen Flanker Task | Primary outcome | ConductCognition |
| Matrix Reasoning | Primary outcome | ConductCognition |
| Mental Rotation | Primary outcome | ConductCognition |
| Pattern and Letter Comparison | Primary outcome | ConductCognition |
| Picture Order Memory Test | Primary outcome | ConductCognition |
| Size Order Memory Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Verbal Learning | Primary outcome | ConductCognition |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.3.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 4a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
Release trials-2026-11-12-0.3.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.